Search research articles
Contact Us
Filters
Showing results (851-860 of 1,023) with videos related to
Page
of 103
Sort By:
European Journal of Heart Failure
|
December 18, 2024
Mortality after high-risk myocardial infarction over the last 20 years: Insights from the VALIANT and PARADISE-MI trials
Alberto Foà, Maria A Pabon, Eugene Braunwald, et al.
Circulation
|
February 8, 2021
Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention: A North American Perspective: 2021 Update
Dominick J Angiolillo, Deepak L Bhatt, Christopher P Cannon, et al.
European Journal of Heart Failure
|
December 26, 2006
Characterization of health-related quality of life in heart failure patients with preserved versus low ejection fraction in CHARM
Eldrin F Lewis, Gervasio A Lamas, Eileen O'Meara, et al.
Chemical Science
|
February 15, 2020
Computationally aided design of a high-performance organic semiconductor: the development of a universal crystal engineering core
Anthony J Petty, Qianxiang Ai, Jeni C Sorli, et al.
European Heart Journal
|
February 6, 2016
Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 2
Hans-Christoph Diener, James Aisenberg, Jack Ansell, et al.
American Heart Journal
|
May 16, 2016
History of bleeding and outcomes with apixaban versus warfarin in patients with atrial fibrillation in the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation trial
Raffaele De Caterina, Ulrika Andersson, John H Alexander, et al.
JAMA
|
November 17, 2014
Extent, location, and clinical significance of non-infarct-related coronary artery disease among patients with ST-elevation myocardial infarction
Duk-Woo Park, Robert M Clare, Phillip J Schulte, et al.
American Heart Journal
|
December 5, 2009
Safety and feasibility of adjunctive antiplatelet therapy with intravenous elinogrel, a direct-acting and reversible P2Y12 ADP-receptor antagonist, before primary percutaneous intervention in patients with ST-elevation myocardial infarction: the Early Rapid ReversAl of platelet thromboSis with intravenous Elinogrel before PCI to optimize reperfusion in acute Myocardial Infarction (ERASE MI) pilot trial
Jeffrey S Berger, Matthew T Roe, C Michael Gibson, et al.
European Heart Journal
|
February 6, 2016
Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 1
Hans-Christoph Diener, James Aisenberg, Jack Ansell, et al.
Journal of the American Heart Association
|
June 3, 2022
Predictors of Recurrent Stroke After Embolic Stroke of Undetermined Source in the RE-SPECT ESUS Trial
Victor J Del Brutto, Han-Christoph Diener, J Donald Easton, et al.
Page
of 103
Search research articles
Search
Showing results (851-860 of 1,023) with videos related to
Sort By:
Page
of 103
European Journal of Heart Failure
|
December 18, 2024
Mortality after high-risk myocardial infarction over the last 20 years: Insights from the VALIANT and PARADISE-MI trials
Alberto Foà, Maria A Pabon, Eugene Braunwald, et al.
Circulation
|
February 8, 2021
Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention: A North American Perspective: 2021 Update
Dominick J Angiolillo, Deepak L Bhatt, Christopher P Cannon, et al.
European Journal of Heart Failure
|
December 26, 2006
Characterization of health-related quality of life in heart failure patients with preserved versus low ejection fraction in CHARM
Eldrin F Lewis, Gervasio A Lamas, Eileen O'Meara, et al.
Chemical Science
|
February 15, 2020
Computationally aided design of a high-performance organic semiconductor: the development of a universal crystal engineering core
Anthony J Petty, Qianxiang Ai, Jeni C Sorli, et al.
European Heart Journal
|
February 6, 2016
Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 2
Hans-Christoph Diener, James Aisenberg, Jack Ansell, et al.
American Heart Journal
|
May 16, 2016
History of bleeding and outcomes with apixaban versus warfarin in patients with atrial fibrillation in the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation trial
Raffaele De Caterina, Ulrika Andersson, John H Alexander, et al.
JAMA
|
November 17, 2014
Extent, location, and clinical significance of non-infarct-related coronary artery disease among patients with ST-elevation myocardial infarction
Duk-Woo Park, Robert M Clare, Phillip J Schulte, et al.
American Heart Journal
|
December 5, 2009
Safety and feasibility of adjunctive antiplatelet therapy with intravenous elinogrel, a direct-acting and reversible P2Y12 ADP-receptor antagonist, before primary percutaneous intervention in patients with ST-elevation myocardial infarction: the Early Rapid ReversAl of platelet thromboSis with intravenous Elinogrel before PCI to optimize reperfusion in acute Myocardial Infarction (ERASE MI) pilot trial
Jeffrey S Berger, Matthew T Roe, C Michael Gibson, et al.
European Heart Journal
|
February 6, 2016
Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 1
Hans-Christoph Diener, James Aisenberg, Jack Ansell, et al.
Journal of the American Heart Association
|
June 3, 2022
Predictors of Recurrent Stroke After Embolic Stroke of Undetermined Source in the RE-SPECT ESUS Trial
Victor J Del Brutto, Han-Christoph Diener, J Donald Easton, et al.
Page
of 103